Overview

Altera Therapeutics is an early stage company developing a first-in-concept cell-penetrating antibody drug conjugates. Current antibody drug conjugates have demonstrated potent effects in the clinic, but serious toxicities and the few generalizable ADC targets across tumor types limit the true potential of these therapies. Our ADC technology leverages a new mechanism of action to tackle these issues, culminating in a highly potent, widely applicable, and safe ADC.